SCD and neoplasm: However, LLC cells (1×105 cells) were co-injected with fibroblasts and tumor growth was monitored for 20 days, we found that the tumor co-injected with fibroblasts form the subcutaneous graft tumor and tumor co-injected with the SCD1-overexpressing fibroblasts grew faster (Figures 5D and S3E).